Additionally, these inclusions are associated with accelerated hippocampal atrophy, cognitive decline, and co-pathology with tau and Aβ, suggesting that TDP-43 may act synergistically with classical AD pathologies to exacerbate neurodegeneration. Here, MAPT is linked to Alzheimer disease.